Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of Quoin Pharmaceuticals Ltd (QNRX) under the Base Case is USD per share. Compared with the current market price of 3.56 USD, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years.
Create a free account · No card needed
Fundamental Analysis
What Quoin Pharmaceuticals Does
Quoin Pharmaceuticals is a biopharmaceutical company focused on rare genetic skin diseases. It develops prescription treatments for conditions that have few or no approved therapies, with programs aimed at disorders such as Netherton syndrome and other severe dermatology diseases. The company’s work is centered on turning drug candidates into medicines that doctors can prescribe to patients with these hard-to-treat conditions.
- Headquarters
- Israel IL
- Employees
- 4
- IPO date
- Nov 1, 1989
Continue QNRX Research
Decided on Quoin Pharmaceuticals? Get an email when QNRX reaches the price you’d buy at. Free with an account.
Other Quoin Pharmaceuticals listings
What is the Intrinsic Value of one QNRX stock?
The intrinsic value for Quoin Pharmaceuticals Ltd (QNRX) under the Base Case is USD.
Is QNRX stock undervalued or overvalued?
Compared with the current market price of 3.56 USD, the stock appears .